Márta Korbonits Selected Research

HLA-B12 antigen

8/2008

HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Márta Korbonits Research Topics

Disease

58	Pituitary Neoplasms (Pituitary Adenoma) 05/2023 - 01/2002
37	Acromegaly 04/2024 - 09/2003
37	Neoplasms (Cancer) 10/2022 - 01/2002
26	Adenoma (Adenomas) 01/2024 - 01/2002
15	Obesity 12/2016 - 08/2002
12	Insulin Resistance 01/2022 - 08/2002
12	Carcinogenesis 01/2019 - 01/2002
11	Cushing Syndrome 08/2023 - 06/2008
9	Gigantism 03/2024 - 01/2012
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 12/2008
8	Growth Hormone-Secreting Pituitary Adenoma 11/2021 - 09/2003
7	Prolactinoma (Prolactinomas) 02/2022 - 12/2008
7	Familial Isolated Pituitary Adenoma 02/2021 - 08/2010
6	Hyperplasia 05/2023 - 07/2005
6	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2018
6	Paraganglioma (Paragangliomas) 10/2022 - 10/2012
6	Carcinoma (Carcinomatosis) 02/2022 - 06/2002
5	Carney Complex 10/2022 - 01/2014
5	Pituitary ACTH Hypersecretion 06/2021 - 12/2003
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2005
5	Prader-Willi Syndrome (Syndrome, Prader-Willi) 10/2014 - 04/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 05/2011
4	ACTH-Secreting Pituitary Adenoma 08/2017 - 06/2002
4	Pheochromocytoma 01/2016 - 07/2013
4	Body Weight (Weight, Body) 01/2013 - 09/2006
4	Type 2 Diabetes Mellitus (MODY) 11/2011 - 06/2007
3	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 03/2024 - 08/2012
3	Diabetes Mellitus 08/2023 - 03/2014
3	Infections 08/2023 - 08/2008
3	Hypertension (High Blood Pressure) 11/2022 - 05/2011
3	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2022 - 01/2014
3	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 05/2018 - 02/2009
3	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 07/2005
3	Feeding and Eating Disorders (Eating Disorder) 10/2014 - 11/2011
3	Endocrine System Diseases (Endocrine Diseases) 03/2012 - 03/2011
3	Abdominal Obesity 12/2008 - 01/2005
3	Starvation 08/2007 - 06/2005
2	Growth Disorders 05/2024 - 08/2023
2	Achondroplasia 08/2023 - 01/2021
2	Penis agenesis 01/2023 - 11/2015
2	Headache (Headaches) 01/2023 - 08/2017
2	Glucose Intolerance 10/2021 - 01/2005
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2014
2	Hypopituitarism (Sheehan's Syndrome) 09/2020 - 01/2020
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 08/2020 - 01/2014
2	Pituitary Apoplexy 01/2020 - 04/2014
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018 - 11/2015

Drug/Important Bio-Agent (IBA)

31	aryl hydrocarbon receptor-interacting proteinIBA 01/2020 - 06/2008
27	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2002
18	Growth Hormone (Somatotropin)IBA 03/2024 - 07/2005
17	GhrelinIBA 10/2014 - 08/2002
16	Hormones (Hormone)IBA 01/2024 - 05/2005
15	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023 - 08/2006
13	Insulin-Like Growth Factor I (IGF-1)IBA 05/2024 - 09/2003
13	ProlactinIBA 05/2023 - 12/2003
12	Insulin (Novolin)FDA Link 03/2024 - 08/2002
12	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 08/2002
11	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2018 - 12/2003
11	Messenger RNA (mRNA)IBA 01/2015 - 01/2002
10	GlucocorticoidsIBA 08/2023 - 12/2003
10	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2003
7	Octreotide (Sandostatin)FDA LinkGeneric 01/2023 - 08/2006
7	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 01/2005
5	Temozolomide (Temodar)FDA LinkGeneric 02/2022 - 04/2009
5	EnzymesIBA 01/2022 - 06/2008
5	MicroRNAs (MicroRNA)IBA 07/2017 - 08/2010
5	Phosphotransferases (Kinase)IBA 07/2017 - 01/2004
4	Metformin (Glucophage)FDA LinkGeneric 08/2023 - 06/2008
4	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019 - 01/2014
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019 - 01/2010
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018 - 07/2005
4	AMP-Activated Protein KinasesIBA 03/2014 - 01/2008
4	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2013 - 01/2002
3	pegvisomant FDA LinkGeneric 04/2024 - 01/2019
3	Testosterone (Sustanon)FDA Link 01/2024 - 02/2015
3	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 08/2023 - 08/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	lanreotide (Somatuline)FDA Link 01/2023 - 08/2012
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 07/2022 - 01/2017
3	Cabergoline FDA LinkGeneric 02/2022 - 09/2017
3	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2016
3	SurvivinIBA 06/2018 - 01/2010
3	Ubiquitin-Specific ProteasesIBA 05/2018 - 07/2015
3	RNA (Ribonucleic Acid)IBA 02/2018 - 12/2003
3	CarbohydratesIBA 01/2018 - 11/2009
3	somatostatin receptor 2IBA 12/2017 - 02/2016
3	Ghrelin ReceptorsIBA 01/2013 - 04/2009
2	4-nitrophenylphosphorylcholine (NPPC)IBA 08/2023 - 01/2021
2	SecretagoguesIBA 01/2023 - 01/2013
2	SteroidsIBA 01/2023 - 11/2022
2	HydrocarbonsIBA 10/2022 - 01/2018
2	Insulin-Like PeptidesIBA 07/2022 - 05/2018
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 12/2017
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 01/2015
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2019 - 12/2008
2	Pituitary HormonesIBA 05/2018 - 05/2014

Therapy/Procedure

16	Therapeutics 11/2022 - 04/2004
7	Radiotherapy 04/2024 - 04/2014
3	Injections 01/2023 - 03/2016
2	Drug Therapy (Chemotherapy) 12/2017 - 12/2016